For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Quanterix Corporation

USPTO Granted Patents = 29

EPO Patents = 6

Trademarks = 7

Forward Citations = 538

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

David C Duffy (21 out of 36 patents)

David M Rissin (15 out of 23 patents)

David Fournier (15 out of 28 patents)

4. Cheuk Wai Kan (10 out of 15 patents)

5. David R Walt (10 out of 79 patents)

6. David Wilson (8 out of 8 patents)

7. Linan Song (7 out of 7 patents)

8. Jeffrey D Randall (6 out of 8 patents)

9. Dandan Shan (5 out of 5 patents)

10. Lei Chang (5 out of 5 patents)

11. John Henrik Zetterberg (4 out of 4 patents)

12. Kaj Blennow (4 out of 5 patents)

13. Todd Campbell (3 out of 5 patents)

14. Andrew Rivnak (3 out of 3 patents)

15. John Lawson (3 out of 6 patents)

Core Competencies:

Phosphorylated Tau Protein

Neurofilament Light Chain

Ultra-Sensitive Detection

Biomarkers

Assays

Immunoassays

Single Molecule Arrays

Dynamic Range Extension

Physiological Samples

Dried Samples

Treatment Protocols

Prognosis

29 patents: Sort by Forward Citations

1. 12571803 - Methods of producing bodily fluid samples containing an analytically quantified amount of phosphorylated tau protein (2026-03-10),

2. 12540950 - Methods of assaying phosphorylated tau protein in a sample (2026-02-03),

3. 12287343 - Quantification of neurofilament light chain in physiological samples (2025-04-29),

4. 12235267 - Ultra-sensitive detection of molecules or particles using beads or other capture objects (2025-02-25),

5. 12130294 - Quantification of biomarkers present in physiological samples (2024-10-29),

6. 12111324 - Quantification of biomarkers present in dried physiological samples (2024-10-08),

7. 12019072 - Methods and systems for extending dynamic range in assays for the detection of molecules or particles (2024-06-25),

8. 11977087 - Systems, devices, and methods for ultra-sensitive detection of molecules or particles (2024-05-07),

9. 11686730 - Quantitative antibody test (2023-06-27),

10. 11619631 - Ultra-sensitive detection of molecules or particles using beads or other capture objects (2023-04-04),

11. 11434264 - Immunoassays for differential detection of clostridium difficile (2022-09-06),

12. 11275092 - Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury (2022-03-15),

13. 11112415 - Systems, devices, and methods for ultra-sensitive detection of molecules or particles (2021-09-07),

14. 10989713 - Methods and systems for extending dynamic range in assays for the detection of molecules or particles (2021-04-27),

15. 10725032 - Ultra-sensitive detection of molecules or particles using beads or other capture objects (2020-07-28),

Company Overview

Quanterix Corporation is a pioneering company specializing in ultra-sensitive biomarker detection technologies. Based in Lexington, MA, it focuses on advancing precision medicine through its innovative platforms that enable the measurement of low-abundance proteins and other biomarkers in various biological samples. Quanterix's technologies are instrumental in research and clinical applications, particularly in the fields of neurology, oncology, and infectious diseases, facilitating breakthroughs in diagnostics and therapeutic development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

29 Patents

#31 in Lexington, MA

#696 in Massachusetts

#11,625 in US

#22,552 in the World

Lexington, MA, United States of America

Quanterix Corporation

Forward Citations = 538

30 inventors:

David C Duffy (21 out of 36 patents)

David M Rissin (15 out of 23 patents)

David Fournier (15 out of 28 patents)

4. Cheuk Wai Kan (10 out of 15 patents)

5. David R Walt (10 out of 79 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Quanterix Corporation. Retrieved from https://idiyas.com/company/quanterix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…